Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection

George Richard Thompson, Nathan P. Wiederhold, Ana C. Vallor, Nyria C. Villareal, James S. Lewis, Thomas F. Patterson

Research output: Contribution to journalArticle

121 Scopus citations

Abstract

We report a case of Candida glabrata invasive candidiasis that developed reduced susceptibility to caspofungin during prolonged therapy. Pre- and posttreatment isolates were confirmed to be isogenic, and sequencing of hot spots known to confer echinocandin resistance revealed an F659V substitution within the FKS2 region of the glucan synthase complex.

Original languageEnglish (US)
Pages (from-to)3783-3785
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume52
Issue number10
DOIs
StatePublished - Oct 2008
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection'. Together they form a unique fingerprint.

Cite this